Cookie use on MRCVSonline
We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive all cookies.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Caterpillar fungus could hold key to new osteoarthritis treatments
The caterpillar fungus Cordyceps militaris could hold the key to new treatments for osteoarthritis.

Active compound can reduce pain and halt disease progression

A fungus that infects caterpillars, Cordyceps militaris, could hold the key to new treatments for osteoarthritis, according to new research.

The study, published in the journal Scientific Reports, suggests that an active compound in the fungus, cordycepin, could reduce pain and halt disease progression.

Scientists say it works by blocking inflammation in an entirely different way to any other pain killer - by repressing a process called polyadenylation - and could be used to help patients for which other treatments have failed.

The study was led by the University of Nottingham and funded by the charity ‘Versus Arthritis’.

“We hope that cordycepin will prove to be the founder of a new class of pain killer,” explained Dr Cornelia De Moor from the University of Nottingham’s School of Pharmacy. “There is a long way to go before a cordycepin-derived medicine reaches patients, but our work is very promising, we are very excited about the prospects.”

Previous work by the University of Nottingham found that cordycepin had anti-inflammatory effects in both cartilage and bone. In this study, researchers administered the compound to rats and mice with osteoarthritis and found that it both reduced pain behaviour and structural damage.

Interestingly, researchers found that cordycepin blocked the inflammation by affecting the last stage of making a messenger RNA, Polyadenylation.

Current treatment options for osteoarthritis are limited to lifestyle changes and reducing pain with non-steroidal anti-inflammatories or opioids. But these have limited efficacy and come with unpleasant side effects.

The team hope that the results from this new research will provide a more effective treatment for osteoarthritis that is less toxic and will, therefore, have fewer side effects for patients.

Dr Stephen Simpson from Versus Arthritis said: “Although in its early stages, the study has great potential suffering pain of musculoskeletal conditions and demonstrated the high value and impact of novel discovery-led research on understanding and treating diseases.”

Image (C) Jose Ramon Pato, Coruña, España.

Become a member or log in to add this story to your CPD history

RCVS carries out annual VN CPD audit

News Story 1
 The RCVS is carrying out its annual veterinary nurse CPD audit and has sent out requests for the CPD records of more than 1,100 nurses this week.

Under the RCVS Code of Professional Conduct, nurses are required to carry out at least 45 hours of CPD over a rolling three-year period. This year, 1,130 nurses have been asked to share their records from 2016-2018 to show that they have complied with the requirements.

Earlier this year, the VN Council decided to expedite the referral process for nurses who have not complied with the CPD requirement for three or more years. In such cases nurses will have their records sent to the CPD Referral Group. 

Click here for more...
News Shorts
Kew Gardens seeking vets for Ethnoveterinary Medicine Project

A new project at the Royal Botanical Gardens, Kew, is seeking the help of vets to find out how plants were traditionally used to treat animals.

The Ethnoveterinary Medicine Project is aiming to record the remaining knowledge from across the British Isles, before it disappears.

Visit the Kew Gardens website for more information or email ethnovet@kew.org to share data.